ArticleDiscover oncology2026

First-line PD-1 inhibitor plus chemotherapy improves outcomes in advanced gastric cancer and correlates with specific biomarkers in a real-world cohort.

Xiaoting Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.